KRONOS BIO INC (KRON) Stock Balance Sheet
NASDAQ:KRON - Nasdaq - US50107A1043 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 91.58M | 84.57M | 64.33M | 76.00M | 198.30M | |||
| Marketable Securities | 8.16M | 27.85M | 108.67M | 162.20M | 141.20M | |||
| Receivables | N/A | N/A | N/A | 600.00K | 800.00K | |||
| Other Current Assets | 2.14M | 2.81M | 5.78M | 5.50M | 7.20M | |||
| Total Current Assets | 101.87M | 115.23M | 178.78M | 244.30M | 347.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.13M | 7.00M | 29.91M | 37.70M | 41.80M | |||
| Investments And Advances | N/A | 0.00 | 1.99M | 9.80M | 0.00 | |||
| Other Non-Current Assets | 2.14M | 2.14M | 2.60M | 3.20M | 2.10M | |||
| Total Non-Current Assets | 6.27M | 9.13M | 34.50M | 50.60M | 43.90M | |||
| TOTAL ASSETS | 108.14M | 124.36M | 213.28M | 294.90M | 391.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 6.31M | 10.96M | 13.82M | 15.30M | 11.20M | |||
| Accounts Payable | 1.57M | 2.40M | 883.00K | 5.00M | 1.00M | |||
| Other Current Liabilities | 0.00 | 1.92M | 9.99M | 1.10M | 1.50M | |||
| Total Current Liabilities | 7.88M | 15.28M | 24.70M | 21.50M | 13.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 20.45M | 21.51M | 29.51M | 29.00M | 32.80M | |||
| Total Non-Current Liabilities | 20.45M | 21.51M | 29.51M | 28.90M | 32.80M | |||
| TOTAL LIABILITIES | 28.33M | 36.78M | 54.20M | 50.40M | 46.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -603.30M | -594.94M | -508.86M | -396.20M | -263.00M | |||
| Additional Paid In Capital | 683.05M | 682.45M | 667.86M | 641.40M | 608.10M | |||
| Common Shares | 61.00K | 60.00K | 59.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 0.00 | 9.00K | 19.00K | -800.00K | 0.00 | |||
| Shares Outstanding | 60.97M | 60.46M | 58.95M | 57.00M | 55.70M | |||
| Tangible Book Value per Share | 1.31 | 1.45 | 2.70 | 4.29 | 6.20 | |||
| Total Shareholders' Equity | 79.81M | 87.58M | 159.08M | 244.50M | 345.10M | |||
| TOTAL LIABILITIES AND EQUITY | 108.14M | 124.36M | 213.28M | 294.90M | 391.50M | |||
| Statistics | ||||||||
| Current Ratio | 12.93 | 7.54 | 7.24 | 11.36 | 25.56 | |||
| Return On Assets (ROA) | -59.63% | -69.22% | -52.83% | -45.17% | -38.59% | |||
| Return On Equity (ROE) | -80.80% | -98.29% | -70.83% | -54.48% | -43.78% | |||
All data in USD , ROIC based on taxRate of 0.21